Grove Bank & Trust’s FibroBiologics FBLG Stock Holding History

Grove Bank & Trust’s Portfolio FBLG Stock Details FBLG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$95	Buy	+100	New	+$116	﹤0.01%	876
2026 Q1	–	Sell	-100	Closed	-$450	–	896
2025 Q4	$450	Hold	100	–	–	﹤0.01%	840
2025 Q3	$1.09K	Hold	100	–	–	﹤0.01%	803
2025 Q2	$1.24K	Hold	100	–	–	﹤0.01%	812
2025 Q1	$1.8K	Buy	100 +50	+100%	+$1.43K	﹤0.01%	788
2024 Q4	$2K	Hold	50	–	–	﹤0.01%	688
2024 Q3	$3.09K	Hold	50	–	–	﹤0.01%	611
2024 Q2	$4.99K	Buy	+50	New	+$9.54K	﹤0.01%	520

Grove Bank & Trust's FBLG Position: Q2 2026 in Review

Grove Bank & Trust opened a new position in FibroBiologics (FBLG) in Q2 2026: 100 shares worth $95. The stake represents ﹤0.01% of the portfolio and ranks #876 among its holdings. This is a return to the name: Grove Bank & Trust previously reported a position in FBLG as recently as Q4 2025.

Grove Bank & Trust first reported a position in FBLG in Q2 2024 and has held it in 8 quarters since. The position peaked at $4.99K in Q2 2024. 1 fund tracked by Wall St. Rank holds FBLG as of Q2 2026.

Grove Bank & Trust held 100 shares of FibroBiologics worth $95 as of Q2 2026.
FibroBiologics was a new Grove Bank & Trust position in Q2 2026.
FibroBiologics made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #876 holding.
Grove Bank & Trust first reported a position in FibroBiologics in Q2 2024 and has held it in 8 quarters since.
Grove Bank & Trust's FibroBiologics position peaked at $4.99K in Q2 2024.
1 fund tracked by Wall St. Rank held FibroBiologics as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.